CML, REFRACTORY

Clinical trials for CML, REFRACTORY explained in plain language.

Never miss a new study

Get alerted when new CML, REFRACTORY trials appear

Sign up with your email to follow new studies for CML, REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Last-Resort leukemia drug made available to patients who have run out of options

Disease control TEMPORARILY_NOT_AVAILABLE

This program gives access to vodobatinib for people with Philadelphia chromosome-positive chronic myeloid leukemia (CML) whose cancer has not responded to previous treatments. It is for patients who still benefit from the drug and have no other treatment choices. The goal is to k…

Matched conditions: CML, REFRACTORY

Sponsor: Sun Pharma Advanced Research Company Limited • Aim: Disease control

Last updated May 11, 2026 20:47 UTC

CML, REFRACTORY

Get alerted when new CML, REFRACTORY trials appear

Last-Resort leukemia drug made available to patients who have run out of options